Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s Patients

Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s Patients

Aucun commentaire sur Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s Patients

Chauvin, P, Bellanger, M, Rapp, T., Sirven N (2020). Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s Patients. Forthcoming in Journal de gestion et d’économie de la santé. (CNRS rang 4).

ADRESSE
45 rue des Saints Pères - 75006 Paris
TELEPHONE & MAIL
01 42 86 20 71 - liraes@u-paris.fr


logo_liraes

Back to Top